{"id":"https://openalex.org/W1511168317","doi":null,"title":"Preclinical evaluation of [F-18]MNI-444. A promising PET imaging agent of adenosine A(2a) receptors.","display_name":"Preclinical evaluation of [F-18]MNI-444. A promising PET imaging agent of adenosine A(2a) receptors.","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W1511168317","mag":"1511168317"},"language":"en","primary_location":{"id":"mag:1511168317","doi":null,"is_oa":false,"landing_page_url":"https://www.research.ed.ac.uk/en/publications/preclinical-evaluation-of-f-18mni-444-a-promising-pet-imaging-age","pdf_url":null,"source":{"id":"https://openalex.org/S90602895","display_name":"Journal of Labelled Compounds and Radiopharmaceuticals","issn_l":"0362-4803","issn":["0362-4803","1099-1344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Labelled Compounds and Radiopharmaceuticals","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001880410","display_name":"David Alagille","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Alagille","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006871150","display_name":"Olivier Barret","orcid":"https://orcid.org/0000-0003-4247-184X","observed_orcids":["https://orcid.org/0000-0003-4247-184X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olivier Barret","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075325587","display_name":"Christine Vala","orcid":"https://orcid.org/0000-0002-7223-5357","observed_orcids":["https://orcid.org/0000-0002-7223-5357"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christine Vala","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":"https://orcid.org/0000-0002-7223-5357","affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075879514","display_name":"Fabien Caill\u00e9","orcid":"https://orcid.org/0000-0003-0088-7337","observed_orcids":["https://orcid.org/0000-0003-0088-7337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabien Caill\u00e9","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":"https://orcid.org/0000-0003-0088-7337","affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073538686","display_name":"Caroline Papin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Papin","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031935223","display_name":"Thomas J. Morley","orcid":"https://orcid.org/0000-0002-0222-3844","observed_orcids":["https://orcid.org/0000-0002-0222-3844"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomas Morley","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067218028","display_name":"Sharon Chih Lin Lee","orcid":"https://orcid.org/0000-0001-8995-9784","observed_orcids":["https://orcid.org/0000-0001-8995-9784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Lee","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":"https://orcid.org/0000-0001-8995-9784","affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049643979","display_name":"Adriana Tavares","orcid":"https://orcid.org/0000-0001-7505-9144","observed_orcids":["https://orcid.org/0000-0001-7505-9144"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adriana Tavares","raw_affiliation_strings":["Deanery of Clinical Sciences"],"raw_orcid":"https://orcid.org/0000-0001-7505-9144","affiliations":[{"raw_affiliation_string":"Deanery of Clinical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037230816","display_name":"John Peter Seibyl","orcid":"https://orcid.org/0000-0002-4917-5413","observed_orcids":["https://orcid.org/0000-0002-4917-5413"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Seibyl","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":"https://orcid.org/0000-0002-4917-5413","affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025268682","display_name":"Gilles D. Tamagnan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gilles Tamagnan","raw_affiliation_strings":["Inst Neurodegenerat Disorders"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inst Neurodegenerat Disorders","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":0.2188,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.55624862,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"56","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.5009999871253967,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.4683000147342682,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0066999997943639755,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.925000011920929},{"id":"https://openalex.org/keywords/pet-imaging-agents","display_name":"PET imaging agents","score":0.8679999709129333},{"id":"https://openalex.org/keywords/radioligands","display_name":"radioligands","score":0.6549999713897705},{"id":"https://openalex.org/keywords/fluorine-18","display_name":"fluorine-18","score":0.7139999866485596},{"id":"https://openalex.org/keywords/preclinical-evaluation","display_name":"preclinical evaluation","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9163174033164978},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.6730685234069824},{"id":"https://openalex.org/C3017724952","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Pet imaging","level":3,"score":0.608562707901001},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.5606581568717957},{"id":"https://openalex.org/C2778172261","wikidata":"https://www.wikidata.org/wiki/Q3796563","display_name":"Imaging agent","level":3,"score":0.5525283813476562},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48198217153549194},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.46291664242744446},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45478948950767517},{"id":"https://openalex.org/C177322064","wikidata":"https://www.wikidata.org/wiki/Q750955","display_name":"Radiochemistry","level":1,"score":0.408794105052948},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.36162319779396057},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24283194541931152},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.12352818250656128},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.10582485795021057},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.06205320358276367},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1511168317","doi":null,"is_oa":false,"landing_page_url":"https://www.research.ed.ac.uk/en/publications/preclinical-evaluation-of-f-18mni-444-a-promising-pet-imaging-age","pdf_url":null,"source":{"id":"https://openalex.org/S90602895","display_name":"Journal of Labelled Compounds and Radiopharmaceuticals","issn_l":"0362-4803","issn":["0362-4803","1099-1344"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Labelled Compounds and Radiopharmaceuticals","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8199999928474426,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1965941138","https://openalex.org/W7099546014","https://openalex.org/W2460332624","https://openalex.org/W2131233318","https://openalex.org/W2410965775","https://openalex.org/W4392603739","https://openalex.org/W3163016038","https://openalex.org/W1988594975","https://openalex.org/W4281256144","https://openalex.org/W3125650026"],"abstract_inverted_index":null,"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}